$39.36
0.82 (+2.13%)
Vertex Pharmaceuticals, Inc. (VRTX)
CAPS Rating:
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

RSS Headlines
Fool UK